The cachexia of malignancy is considered mediated through excess production of tumor necrosis factor–alpha and other cytokines. Thalidomide (Thalomid), a sedative/hypnotic, has been shown to inhibit tumor necrosis factor–alpha production.
M. Weisberg
Advertisement
Articles by M. Weisberg
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Capivasertib Combo Earns FDA Approval in PTEN-Deficient Metastatic HSPC
2
FDA Approves Adjuvant Belzutifan/Pembrolizumab in Clear Cell RCC Post Nephrectomy
3
VT-EBV-N Yields Durable Disease-Free Survival in Pretreated ENKTL
4
Anbenitamab Regimen Meets Phase 3 End Points in HER2+ Breast Cancer
5